glp 1 and anorexia Today @wsj reported on an important phenomenon that eating disorder professionals have been warning is on the rise in their practices: GLP-1 usage creating a runway to nervosa in some users Beyond Weight Loss: GLP-1 Usage

This is what it must feel like for someone who doesn't have to live with obesity, who has normal appetite regulation and is not thinking about food all the time, which we now call food noise

GLP-1 medications usually cost several hundred to over one thousand dollars each month when paid in cash

Al mismo tiempo, Gallup seala que la tasa de obesidad entre los estadounidenses descendi al 36,4% en 2026, desde un mximo histrico del 39,9% en 2022, el ao posterior a la aprobacin por primera vez del medicamento GLP-1 Wegovy por la Administracin de Alimentos y Medicamentos (FDA) para el tratamiento de la prdida de peso

Dosing information Usual Adult Dose of Bydureon BCisefor Diabetes Type 2: Extended-release: Initial dose - 2 mg subcutaneously once every 7 days (weekly) -May administer any time of day, with or without meals

The 80mg total across four components in 3mL gives a combined concentration of approximately 26.67mg/mL

We talk through any history of cancer, pituitary disease, or diabetes first, since the protocol isn't appropriate with active or recent cancer or with pituitary disease, and there's no safety data in pregnancy or breastfeeding